American Association for Cancer Research

SHERPA: White

People

  1. Rosen
    Rosen
  2. Scher
    Scher
  3. Ladanyi
    Ladanyi
  4. Solit
    Solit
  5. De Stanchina
    De Stanchina
  6. Houghton
    Houghton
  7. Cheung
    Cheung
  8. Orlow
    Orlow
  9. Kris
    Kris
  10. Sirotnak
    Sirotnak

Groups

  1. Department of Medicine (759)
  2. GSK Faculty (569)
  3. Solid Tumor Oncology Division (542)
  4. Sloan Kettering Institute Faculty (386)
  5. Sloan Kettering Institute Postdocs (266)
  6. Surgery (257)
  7. Epidemiology and Biostatistics (240)
  8. Population Sciences Research Program (236)
  9. Molecular Pharmacology and Chemistry Program Faculty (221)
  10. Center for Hematologic Malignancies (218)
Search Within
Formats
  1. Meeting Abstract (1046)
  2. Journal Article (782)
  3. Editorial (36)
  4. Review (27)
Groups
  1. Department of Medicine (759)
  2. GSK Faculty (569)
  3. Solid Tumor Oncology Division (542)
  4. Sloan Kettering Institute Faculty (386)
  5. Sloan Kettering Institute Postdocs (266)
  6. Surgery (257)

More Groups

People
  1. Joseph Bertino (93)
  2. Neal Rosen (70)
  3. Howard Scher (58)
  4. Carlos Cordon-Cardo (54)
  5. Debabrata Banerjee (47)
  6. Marc Ladanyi (44)

More People

Years
  1. 2025 (32)
  2. 2024 (63)
  3. 2023 (65)
  4. 2022 (71)
  5. 2021 (62)
  6. 2020 (85)

More Years

Publications
  1. Proceedings of the American Association for Cancer Research Annual Meeting (924)
  2. Cancer Discovery (294)
  3. Cancer Epidemiology Biomarkers and Prevention (249)
  4. Molecular Cancer Therapeutics (124)
  5. Cancer Immunology Research (103)
  6. Molecular Cancer Research (68)

More Publications

Results (1891)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Global regulation of the histone mark H3K36me2 underlies epithelial plasticity and metastatic progression
    Journal Article

    Yuan, S.; Natesan, R.; Sanchez-Rivera, F. J.; Li, J.; Bhanu, N. V.; Yamazoe, T.; Lin, J. H.; Merrell, A. J.; Sela, Y.; Thomas, S. K.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Excessive costimulation leads to dysfunction of adoptively transferred T cells
    Journal Article

    Wijewarnasuriya, D.; Bebernitz, C.; Lopez, A. V.; Rafiq, S.; Brentjens, R. J.
    Cancer Immunology Research (2020)

    Fulltext@MSK | Save
  • Optimization of T-cell receptor-modified T cells for cancer therapy
    Journal Article

    Drakes, D. J.; Rafiq, S.; Purdon, T. J.; Lopez, A. V.; Chandran, S. S.; Klebanoff, C. A.; Brentjens, R. J.
    Cancer Immunology Research (2020)

    Fulltext@MSK | Save
  • Mutations in the RNA splicing factor SF3B1 promote tumorigenesis through MYC stabilization
    Journal Article

    Liu, Z.; Yoshimi, A.; Wang, J.; Cho, H.; Chun-Wei Lee, S.; Ki, M.; Bitner, L.; Chu, T.; Shah, H.; Liu, B.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • KRAS and RAS signaling network is co-regulated and can be therapeutically blocked by targeting eIF4A dependent translation program
    Meeting Abstract

    Singh, K.; Lin, J.; Lecomte, N.; Mohan, P.; Gokce, A.; Sanghvi, V.; Olivera, G. H.; Jiang, M.; Burčul, A.; Stark, S.; more...
    Molecular Cancer Research (2020)

    Fulltext@MSK | Save
  • Identification of the targets of T-cell receptor therapeutic agents and cells by use of a high-throughput genetic platform
    Journal Article

    Gejman, R. S.; Jones, H. F.; Klatt, M. G.; Chang, A. Y.; Oh, C. Y.; Chandran, S. S.; Korontsvit, T.; Zakahleva, V.; Dao, T.; Klebanoff, C. A.; more...
    Cancer Immunology Research (2020)

    Fulltext@MSK | Save
  • Targeting HER2 with trastuzumab deruxtecan: A dose-expansion, phase I study in multiple advanced solid tumors
    Journal Article

    Tsurutani, J.; Iwata, H.; Krop, I.; Jänne, P. A.; Doi, T.; Takahashi, S.; Park, H.; Redfern, C.; Tamura, K.; Wise-Draper, T. M.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Lipid trait variants and the risk of non-Hodgkin lymphoma subtypes: A Mendelian randomization study
    Journal Article

    Kleinstern, G.; Camp, N. J.; Berndt, S. I.; Birmann, B. M.; Nieters, A.; Bracci, P. M.; McKay, J. D.; Ghesquières, H.; Lan, Q.; Hjalgrim, H.; more...
    Cancer Epidemiology Biomarkers and Prevention (2020)

    Fulltext@MSK | Save
  • Pan-cancer efficacy of vemurafenib in BRAF(V600)-mutant non-melanoma cancers
    Journal Article

    Subbiah, V.; Puzanov, I.; Blay, J. Y.; Chau, I.; Lockhart, A. C.; Raje, N. S.; Wolf, J.; Baselga, J.; Meric-Bernstam, F.; Roszik, J.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • HER2-mediated internalization of cytotoxic agents in ERBB2 amplified or mutant lung cancers
    Journal Article

    Li, B. T.; Michelini, F.; Misale, S.; Cocco, E.; Baldino, L.; Cai, Y.; Shifman, S.; Tu, H. Y.; Myers, M. L.; Xu, C.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save